AbbVie/Roche’s Venclexta is Set to Remain the Acute Myeloid Leukemia Drugs Market Leader | GlobalData Plc LONDON, July 14, 2022 (GLOBE NEWSWIRE) -- The “Acute Myeloid Leukemia (AML) – Opportunity Analysis and Forecasts to 2029” report offered by GlobalData provides an overview of AML including...